Topline Results from Phase 2 CELIA Study of Diranersen (BIIB080): First Study to Show Reduction in Tau Pathology and Cognitive Benefit in Patients with Early Alzheimer’s Disease

Robust reductions in tau pathology were observed across all studied doses, with results generally consistent with those observed in the Phase 1b ...

Charlie Munger Said Houses Are 'Monetized' Like Never Before — Calls Buying Cadillac With Home Equity 'Revolting'

For a lot of Americans, the house stopped being just a house somewhere between the kitchen remodel and the shiny SUV parked ...